Abstract:Background and objectives Direct pulp capping (dPC) is a therapeutic process that involves the application of a protective chemical to an exposed pulp with the intent to facilitate the restoration and preservation of its vitality and function. Despite numerous proposed solutions, researchers have yet to find a dependable, non-absorbable bioactive pulp capping substance that constantly activates cellular healing processes, consequently preserving pulpal vitality over an extended period of time. The objective of this study was to assess and contrast the efficacy of a novel tricalcium silicate cement and calcium hydroxide in preserving the long-term health of the dental pulp following dPC using clinical and radiographic observations. Materials and methods A total of 60 individuals with symptoms of reversible pulpitis associated with deep carious lesions were chosen for dPC in the study. Two groups comprising 30 patients each underwent dPC using the novel tricalcium silicate cement (experimental group) and calcium hydroxide (control group) out of the total number of patients. A thin protective covering of self-curing glass ionomer base was applied on top of the capping material. The dentist provided instant permanent restoration employing direct posterior composite resin. Follow-up examinations were conducted three, six, nine, and 12 months after the procedure, during which assessments were performed using clinical and radiographic parameters. Results The minimum age of the study group was 16, and its maximum age was 34 (22.35 ± 2.3 years). The control group consisted of 12 males and 18 females, while the Biodentine group consisted of 13 males and 17 females. The age and gender distribution were determined to have insignificant statistical differences across the groups. The pain score exhibited statistical significance at both the three-month and six-month follow-up visits (p < 0.05). The pain score at the 12-month follow-up was 0.38 ± 0.52 in the case group and 0.42 ± 0.61 in the control group (p = 0.79). The average Periapical Index (PAI) score for the Dycal and Biodentin groups after the 12-month follow-up was 1.38 ± 0.97 and 1 ± 0.3, respectively. This difference was found to be statistically significant (p = 0.044). In addition, there was a statistically significant difference in the PAI score at the three-month, six-month, and nine-month follow-ups (p < 0.01). During the entirety of the follow-up duration, one individual in the Biodentine group had tenderness upon percussion, a negative reaction for pulp vitality, pulpal changes, and a widening of the periodontal space. Statistically significant differences were observed in pulpal changes and tenderness on percussion during the nine-month and 12-month follow-up periods (p < 0.05). After 12 months, the rate of success in the group treated with Dycal was 91.3%, while the success percentage in the group treated with Biodentine was 98.55%. This difference in outcomes was determined to be statistically significant (λ2 = 5.46; p = 0.019). Conclusion The study findings indicate that Biodentine, a novel tricalcium silicate cement, outperforms calcium hydroxide in preserving pulp vitality over the long term following dPC. The Biodentine group attained an overall success rate of 98.55%, whereas the Dycal group had a success rate of 91.3% following 12 months of subsequent follow-up visits.

An in Vitro Investigation of the Mechanical-Chemical and Biological Properties of Calcium Phosphate/Calcium Silicate/Bismutite Cement for Dental Pulp Capping

A Novel Silicate‐doped Calcium‐based Composite Dental Pulp Capping Agent

In vitro evaluation of antimicrobial activity of new calcium phosphate cement compound for pulp-capping

Systematic Investigation of Β-Dicalcium Silicate-Based Bone Cements in Vitro and in Vivo in Comparison with Clinically Applied Calcium Phosphate Cement and Bio-Oss®

Differentiation inducement of calcium phosphate/calcium silicate/bismutite cement to dental pulp cells in vitro

Antibacterial, biocompatible, and mineralization‐inducing properties of calcium silicate‐based cements

Calcium Silicate and Calcium Hydroxide Materials for Pulp Capping: Biointeractivity, Porosity, Solubility and Bioactivity of Current Formulations

Development of calcium phosphate/sulfate biphasic cement for vital pulp therapy

Bioactive Calcium Phosphate Cement with Excellent Injectability, Mineralization Capacity and Drug-Delivery Properties for Dental Biomimetic Reconstruction and Minimum Intervention Therapy

Enhanced Reparative Dentinogenesis of Biphasic Calcium Phosphate Ceramics Containing Calcium-deficient Hydroxyapatite (CDHA) and Strontium-incorporated CDHA in Direct Pulp Capping

A Biphasic Calcium Phosphate Cement Enhances Dentin Regeneration by Dental Pulp Stem Cells and Promotes Macrophages M2 Phenotype In Vitro

Chemical and Physical Properties of Contemporary Pulp Capping Materials

Experimental Pulp-Capping Agent Radiopaque Dicalcium Silicate Cement Facilitates Dentinogenesis

Comparative Evaluation of a New Tricalcium Silicate Cement With Calcium Hydroxide as Direct Pulp Capping Agents: A Clinical Study

Calcium Silicate-Based Biocompatible Light-Curable Dental Material for Dental Pulpal Complex

A Comprehensive Study of Osteogenic Calcium Phosphate Silicate Cement: Material Characterization and In Vitro/In Vivo Testing.

Physical evaluation of a new pulp capping material developed from portland cement

Effects of silicate-based composite material on the proliferation and mineralization behaviors of human dental pulp cells: An in vitro assessment

Evaluation of Pulp Response to Novel Bioactive Glass Pulp Capping Materials.

Cytotoxicity and osteogenic potential of silicate calcium cements as potential protective materials for pulpal revascularization.

In Vitro Self‐setting Properties, Bioactivity, and Antibacterial Ability of a Silicate‐based Premixed Bone Cement